Six adults with type 1 diabetes (T1D) treated with stem cell-derived islet cells (VX-880) have shown improved blood sugar control, with three participants achieving insulin independence, according to new research being presented ...
Oct 3, 2023
0
2
Patients with non-alcoholic fatty liver disease (NAFLD) are more likely to suffer with a personality disorder than people without the condition, a new study reveals.
Oct 3, 2023
0
5
It's normal to have bacteria in your mouth. But harmful bacteria have been linked to a host of health problems. Medical scientist Glenda Davison and microbiologist Yvonne Prince, who have researched the oral cavity, explain ...
Oct 3, 2023
0
18
Fatty liver disease is exploding globally, affecting as many as 30% of people in Western countries. Apart from alcohol, obesity and diabetes are among the most dominant risk factors.
Oct 2, 2023
0
0
UVA Health researchers have developed a powerful new tool to understand how medications affect men and women differently, and that will help lead to safer, more effective drugs in the future.
Oct 2, 2023
0
31
Memory B cells depend on autophagy for their survival, but the protein Rubicon is thought to hinder this process. Researchers from Osaka University have discovered a shorter isoform of Rubicon called RUBCN100, which enhances ...
Oct 2, 2023
0
59
Chronic hepatitis B virus (HBV) infection poses a significant threat to global public health, contributing to liver-related morbidity and mortality. The current diagnostic methods for HBV-related diseases, such as laboratory ...
Sep 28, 2023
0
9
A team of researchers has uncovered a previously unknown compensatory mechanism found in liver disease. If Kupffer cells (KCs), a specific kind of immune cells found in the liver, become impaired by tissue scarring, immune ...
Sep 28, 2023
0
38
Results from the largest ever review of clinical trials in cancer screening, prevention, and early detection (SPED) have been published.
Sep 28, 2023
0
1
A severe form of fatty liver disease called nonalcoholic steatohepatitis (NASH) is the leading cause of liver transplantation, but there are few treatment options and currently no medications. In a new study, Yale researchers ...
Sep 27, 2023
0
85
